Global Eculizumab Sales Market Report 2020 by Manufacturer, Region, Type and Application

Published: Nov, 2019 | Pages: 107 | Publisher: XYZResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

In this report, in the last several years, Global market of Eculizumab developed rapidly, with an average growth rate of 34%. In 2016, Global Revenue of Eculizumab was nearly 2850 M USD; the actual production was about 460 thousand units.

Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.

The classification of Eculizumab includes Plasma Exchange and Plasma Infusion, and the proportion of Plasma Exchange in 2016 was about 72%, and the proportion was in increasing trend from 2012 to 2016.

Eculizumab is widely used for patients of PNH, aHUS and others. The most proportion of Eculizumab was used for patients of aHUS, and the proportion in 2016 was about 55%.

North America was the largest consumption place, with a consumption market share nearly 40.3% in 2016. Following North America, Europe was the second largest consumption place with the consumption market share of 32.6%. 

Alexion is the major player in global Eculizumab market. Soliris (eculizumab) is the first and only therapeutic approved for patients with either paroxysmal nocturnal hemoglobinuria (PNH), a lifethreatening and ultra-rare genetic blood disorder, or atypical hemolytic uremic syndrome (aHUS), a life-threatening and ultra-rare genetic disease. PNH and aHUS result from chronic uncontrolled activation of the complement component of the immune system.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Eculizumab for these regions, from 2014 to 2026 (forecast), covering
    China
    USA
    Europe
    Japan
    Korea
    India
    Southeast Asia
    South America

Global Eculizumab market competition by top manufacturers/players, with Eculizumab sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
    Alexion
    ...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Plasma Exchange
    Plasma Infusion
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Eculizumab for each application, including
    PNH
    aHUS
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

1 Executive Summary
    1.1 Definition and Specification
    1.2 Report Overview
        1.2.1 Manufacturers Overview
        1.2.2 Regions Overview
        1.2.3 Type Overview
        1.2.4 Application Overview
    1.3 Industrial Chain
        1.3.1 Eculizumab Overall Industrial Chain
        1.3.2 Upstream
        1.3.3 Downstream
    1.4 Industry Situation
        1.4.1 Industrial Policy
        1.4.2 Product Preference
        1.4.3 Economic/Political Environment
    1.5 SWOT Analysis
2 Market Analysis by Types
    2.1 Overall Market Performance(Volume)
         2.1.1 Plasma Exchange
         2.1.2 Plasma Infusion
    2.2 Overall Market Performance(Value)
         2.2.1 Plasma Exchange
         2.2.2 Plasma Infusion
3 Product Application Market
    3.1 Overall Market Performance (Volume)
         3.1.1 PNH
         3.1.2 aHUS
         3.1.3 Other
4 Manufacturers Profiles/Analysis
    4.1 Alexion
        4.1.1 Alexion Profiles
        4.1.2 Alexion Product Information
        4.1.3 Alexion Eculizumab Sales, Sales Value(Million USD), Price and Gross Profit
        4.1.4 Alexion SWOT Analysis
5 Market Performance for Manufacturers
    5.1 Global Eculizumab Sales (K Units) and Market Share by Manufacturers 2014-2020
    5.2 Global Eculizumab Revenue (M USD) and Market Share by Manufacturers 2014-2020
    5.3 Global Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
    5.4 Global Eculizumab Gross Margin of Manufacturers 2014-2020
    5.5 Market Concentration
6 Regions Market Performance for Manufacturers
    6.1 China Market Performance for Manufacturers
        6.1.1 China Eculizumab Sales (K Units) and Share of Manufacturers 2014-2020
        6.1.2 China Eculizumab Revenue (M USD) and Share of Manufacturers 2014-2020
        6.1.3 China Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
        6.1.4 China Eculizumab Gross Margin of Manufacturers 2014-2020
        6.1.5 Market Concentration
    6.2 USA Market Performance for Manufacturers
        6.2.1 USA Eculizumab Sales (K Units) and Share of Manufacturers 2014-2020
        6.2.2 USA Eculizumab Revenue (M USD) and Share of Manufacturers 2014-2020
        6.2.3 USA Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
        6.2.4 USA Eculizumab Gross Margin of Manufacturers 2014-2020
        6.2.5 Market Concentration
    6.3 Europe Market Performance for Manufacturers
        6.3.1 Europe Eculizumab Sales (K Units) and Share of Manufacturers 2014-2020
        6.3.2 Europe Eculizumab Revenue (M USD) and Share of Manufacturers 2014-2020
        6.3.3 Europe Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
        6.3.4 Europe Eculizumab Gross Margin of Manufacturers 2014-2020
        6.3.5 Market Concentration
    6.4 Japan Market Performance for Manufacturers
        6.4.1 Japan Eculizumab Sales (K Units) and Share of Manufacturers 2014-2020
        6.4.2 Japan Eculizumab Revenue (M USD) and Share of Manufacturers 2014-2020
        6.4.3 Japan Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
        6.4.4 Japan Eculizumab Gross Margin of Manufacturers 2014-2020
        6.4.5 Market Concentration
    6.5 Korea Market Performance for Manufacturers
        6.5.1 Korea Eculizumab Sales (K Units) and Share of Manufacturers 2014-2020
        6.5.2 Korea Eculizumab Revenue (M USD) and Share of Manufacturers 2014-2020
        6.5.3 Korea Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
        6.5.4 Korea Eculizumab Gross Margin of Manufacturers 2014-2020
        6.5.5 Market Concentration
    6.6 India Market Performance for Manufacturers
        6.6.1 India Eculizumab Sales (K Units) and Share of Manufacturers 2014-2020
        6.6.2 India Eculizumab Revenue (M USD) and Share of Manufacturers 2014-2020
        6.6.3 India Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
        6.6.4 India Eculizumab Gross Margin of Manufacturers 2014-2020
        6.6.5 Market Concentration
    6.7 Southeast Asia Market Performance for Manufacturers
        6.7.1 Southeast Asia Eculizumab Sales (K Units) and Share of Manufacturers 2014-2020
        6.7.2 Southeast Asia Eculizumab Revenue (M USD) and Share of Manufacturers 2014-2020
        6.7.3 Southeast Asia Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
        6.7.4 Southeast Asia Eculizumab Gross Margin of Manufacturers 2014-2020
        6.7.5 Market Concentration
    6.8 South America Market Performance for Manufacturers
        6.8.1 South America Eculizumab Sales (K Units) and Share of Manufacturers 2014-2020
        6.8.2 South America Eculizumab Revenue (M USD) and Share of Manufacturers 2014-2020
        6.8.3 South America Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
        6.8.4 South America Eculizumab Gross Margin of Manufacturers 2014-2020
        6.8.5 Market Concentration
7 Global  Eculizumab Market Assessment by Regions (2014-2020)
    7.1 Global Eculizumab Sales (K Units) and Market Share by Regions 2014-2020
    7.2 Global Eculizumab Revenue (M USD) and Market Share by Regions 2014-2020
    7.3 Global Eculizumab Price (USD/Unit) by Regions 2014-2020
    7.4 Global Eculizumab Gross Margin by Regions 2014-2020
8 Development Trend for Regions
    8.1 Global Eculizumab Sales and Growth, Sales Value and Growth Rate 2014-2020
    8.2 China Eculizumab Sales and Growth, Sales Value and Growth Rate 2014-2020
    8.3 USA Eculizumab Sales and Growth, Sales Value and Growth Rate2014-2020
    8.4 Europe Eculizumab Sales and Growth, Sales Value and Growth Rate 2014-2020
    8.5 Japan Eculizumab Sales and Growth, Sales Value and Growth Rate 2014-2020
    8.6 Korea Eculizumab Sales and Growth, Sales Value and Growth Rate 2014-2020
    8.7 India Eculizumab Sales and Growth, Sales Value and Growth Rate 2014-2020
    8.8 Southeast Asia Eculizumab Sales and Growth, Sales Value and Growth Rate 2014-2020
    8.8 Southeast Asia Eculizumab Sales and Growth, Sales Value and Growth Rate 2014-2020
9 Upstream Source, Technology and Cost
    9.1 Upstream Source
    9.2 Technology
    9.3 Cost
10 Channel Analysis
    10.1 Market Channel
    10.2 Manufacturing Plants Distribution
11 Consumer Analysis
    11.1 PNH Industry
    11.2 aHUS Industry
    11.3 Other Industry
12 Market Forecast 2021-2026
    12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
        12.1.1 Global Eculizumab Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
        12.1.2 Global Eculizumab Sales (K Units) and Growth Rate 2021-2026
        12.1.3 China Eculizumab Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
        12.1.4 USA Eculizumab Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
        12.1.5 Europe Eculizumab Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
        12.1.6 Japan Eculizumab Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
        12.1.7 Korea Eculizumab Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
        12.1.8 India Eculizumab Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
        12.1.9 Southeast Asia Eculizumab Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
        12.1.10 South America Eculizumab Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
        12.2.1 Overall Market Performance
        12.2.2 Plasma Exchange
        12.2.3 Plasma Infusion
    12.3 Sales  (K Units) Forecast by Application 2021-2026
        12.3.1 Overall Market Performance
        12.3.2 PNH
        12.3.3 aHUS
        12.3.4 Other
    12.4 Price (USD/Unit) and Gross Profit
        12.4.1 Global Eculizumab Price (USD/Unit) Trend 2021-2026
        12.4.2 Global Eculizumab Gross Profit Trend 2021-2026
13 Conclusion

List of Tables and Figures

Figure Product Picture of Eculizumab
Table Product Specifications of Eculizumab
Table Manufacturers List in the Report
Table Manufacturers Production Market Share (%) 2014-2020
Table Regions Overview in 2020
Table Product Type and Standard
Table Type Overview in 2020
Table Product Application and Standard
Table Application Overview in 2020
Figure Industry Chain Structure of Eculizumab
Table Industry News List of Eculizumab
Table Key Challenges
Table Global Eculizumab Sales (K Units) by Types
Figure Global Eculizumab Sales Market Share (%) by Types in 2014
Figure Global Eculizumab Sales Market Share (%) by Types in 2020
Table Plasma Exchange Sales (K Units) and Growth Rate
Figure Plasma Exchange Sales (K Units) and Growth Rate
Table Plasma Infusion Sales (K Units) and Growth Rate
Figure Plasma Infusion Sales (K Units) and Growth Rate
Table Global Eculizumab Revenue (M USD) by Types
Figure Global Eculizumab Revenue Market Share (%) by Types in 2014
Figure Global Eculizumab Revenue Market Share (%) by Types in 2020
Table Plasma Exchange Revenue (M USD) and Growth Rate
Figure Plasma Exchange Revenue (M USD) and Growth Rate
Table Plasma Infusion Revenue (M USD) and Growth Rate
Figure Plasma Infusion Revenue (M USD) and Growth Rate
Table Global Eculizumab Sales (K Units) by Application 2014-2020
Figure Global Eculizumab Sales Market Share (%) by Application in 2014
Figure Global Eculizumab Sales Market Share (%) by Application in 2020
Table PNH Sales (K Units) and Growth Rate 2014-2020
Figure PNH Sales (K Units) and Growth Rate 2014-2020
Table aHUS Sales (K Units) and Growth Rate 2014-2020
Figure aHUS Sales (K Units) and Growth Rate 2014-2020
Table Other Sales (K Units) and Growth Rate 2014-2020
Figure Other Sales (K Units) and Growth Rate 2014-2020
Table Alexion Profiles
Table Alexion Product Information
Table Alexion Eculizumab Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Alexion Eculizumab Sales Change 2014-2020
Table Alexion Eculizumab Market Status Change 2014-2020
Table Global Eculizumab Sales (K Units) of Manufacturers 2014-2020
Table Global Eculizumab Sales Market Share (%) of Manufacturers 2014-2020
Figure Global Eculizumab Sales Market Share (%) in 2014
Figure Global Eculizumab Sales Market Share (%) in 2020
Table Global Eculizumab Revenue (M USD) of Manufacturers 2014-2020
Table Global Eculizumab Revenue Market Share (%) of Manufacturers 2014-2020
Figure Global Eculizumab Revenue Market Share (%) in 2014
Figure Global Eculizumab Revenue Market Share (%) in 2020
Table Global Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
Figure Global Eculizumab Price (USD/Unit) of Manufacturers in 2014
Figure Global Eculizumab Price (USD/Unit) of Manufacturers in 2020
Table Global Eculizumab Gross Margin of Manufacturers 2014-2020
Figure Global Eculizumab Gross Margin of Manufacturers in 2014
Figure Global Eculizumab Gross Margin in 2020
Figure Global Eculizumab Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table USA Eculizumab Sales (K Units) of Manufacturers 2014-2020
Table USA Eculizumab Sales Market Share (%) of Manufacturers 2014-2020
Figure USA Eculizumab Sales Market Share (%) in 2014
Figure USA Eculizumab Sales Market Share (%) in 2020
Table USA Eculizumab Revenue (M USD) of Manufacturers 2014-2020
Table USA Eculizumab Revenue Market Share (%) of Manufacturers 2014-2020
Figure USA Eculizumab Revenue Market Share (%) in 2014
Figure USA Eculizumab Revenue Market Share (%) in 2020
Table USA Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
Figure USA Eculizumab Price (USD/Unit) of Manufacturers in 2014
Figure USA Eculizumab Price (USD/Unit) of Manufacturers in 2020
Table USA Eculizumab Gross Margin of Manufacturers 2014-2020
Figure USA Eculizumab Gross Margin of Manufacturers in 2014
Figure USA Eculizumab Gross Margin in 2020
Figure USA Eculizumab Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Europe Eculizumab Sales (K Units) of Manufacturers 2014-2020
Table Europe Eculizumab Sales Market Share (%) of Manufacturers 2014-2020
Figure Europe Eculizumab Sales Market Share (%) in 2014
Figure Europe Eculizumab Sales Market Share (%) in 2020
Table Europe Eculizumab Revenue (M USD) of Manufacturers 2014-2020
Table Europe Eculizumab Revenue Market Share (%) of Manufacturers 2014-2020
Figure Europe Eculizumab Revenue Market Share (%) in 2014
Figure Europe Eculizumab Revenue Market Share (%) in 2020
Table Europe Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
Figure Europe Eculizumab Price (USD/Unit) of Manufacturers in 2014
Figure Europe Eculizumab Price (USD/Unit) of Manufacturers in 2020
Table Europe Eculizumab Gross Margin of Manufacturers 2014-2020
Figure Europe Eculizumab Gross Margin of Manufacturers in 2014
Figure Europe Eculizumab Gross Margin in 2020
Figure Europe Eculizumab Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Japan Eculizumab Sales (K Units) of Manufacturers 2014-2020
Table Japan Eculizumab Sales Market Share (%) of Manufacturers 2014-2020
Figure Japan Eculizumab Sales Market Share (%) in 2014
Figure Japan Eculizumab Sales Market Share (%) in 2020
Table Japan Eculizumab Revenue (M USD) of Manufacturers 2014-2020
Table Japan Eculizumab Revenue Market Share (%) of Manufacturers 2014-2020
Figure Japan Eculizumab Revenue Market Share (%) in 2014
Figure Japan Eculizumab Revenue Market Share (%) in 2020
Table Japan Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
Figure Japan Eculizumab Price (USD/Unit) of Manufacturers in 2014
Figure Japan Eculizumab Price (USD/Unit) of Manufacturers in 2020
Table Japan Eculizumab Gross Margin of Manufacturers 2014-2020
Figure Japan Eculizumab Gross Margin of Manufacturers in 2014
Figure Japan Eculizumab Gross Margin in 2020
Figure Japan Eculizumab Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Korea Eculizumab Sales (K Units) of Manufacturers 2014-2020
Table Korea Eculizumab Sales Market Share (%) of Manufacturers 2014-2020
Figure Korea Eculizumab Sales Market Share (%) in 2014
Figure Korea Eculizumab Sales Market Share (%) in 2020
Table Korea Eculizumab Revenue (M USD) of Manufacturers 2014-2020
Table Korea Eculizumab Revenue Market Share (%) of Manufacturers 2014-2020
Figure Korea Eculizumab Revenue Market Share (%) in 2014
Figure Korea Eculizumab Revenue Market Share (%) in 2020
Table Korea Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
Figure Korea Eculizumab Price (USD/Unit) of Manufacturers in 2014
Figure Korea Eculizumab Price (USD/Unit) of Manufacturers in 2020
Table Korea Eculizumab Gross Margin of Manufacturers 2014-2020
Figure Korea Eculizumab Gross Margin of Manufacturers in 2014
Figure Korea Eculizumab Gross Margin in 2020
Figure Korea Eculizumab Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table India Eculizumab Sales (K Units) of Manufacturers 2014-2020
Table India Eculizumab Sales Market Share (%) of Manufacturers 2014-2020
Figure India Eculizumab Sales Market Share (%) in 2014
Figure India Eculizumab Sales Market Share (%) in 2020
Table India Eculizumab Revenue (M USD) of Manufacturers 2014-2020
Table India Eculizumab Revenue Market Share (%) of Manufacturers 2014-2020
Figure India Eculizumab Revenue Market Share (%) in 2014
Figure India Eculizumab Revenue Market Share (%) in 2020
Table India Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
Figure India Eculizumab Price (USD/Unit) of Manufacturers in 2014
Figure India Eculizumab Price (USD/Unit) of Manufacturers in 2020
Table India Eculizumab Gross Margin of Manufacturers 2014-2020
Figure India Eculizumab Gross Margin of Manufacturers in 2014
Figure India Eculizumab Gross Margin in 2020
Figure India Eculizumab Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Southeast Asia Eculizumab Sales (K Units) of Manufacturers 2014-2020
Table Southeast Asia Eculizumab Sales Market Share (%) of Manufacturers 2014-2020
Figure Southeast Asia Eculizumab Sales Market Share (%) in 2014
Figure Southeast Asia Eculizumab Sales Market Share (%) in 2020
Table Southeast Asia Eculizumab Revenue (M USD) of Manufacturers 2014-2020
Table Southeast Asia Eculizumab Revenue Market Share (%) of Manufacturers 2014-2020
Figure Southeast Asia Eculizumab Revenue Market Share (%) in 2014
Figure Southeast Asia Eculizumab Revenue Market Share (%) in 2020
Table Southeast Asia Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
Figure Southeast Asia Eculizumab Price (USD/Unit) of Manufacturers in 2014
Figure Southeast Asia Eculizumab Price (USD/Unit) of Manufacturers in 2020
Table Southeast Asia Eculizumab Gross Margin of Manufacturers 2014-2020
Figure Southeast Asia Eculizumab Gross Margin of Manufacturers in 2014
Figure Southeast Asia Eculizumab Gross Margin in 2020
Figure Southeast Asia Eculizumab Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table South America Eculizumab Sales (K Units) of Manufacturers 2014-2020
Table South America Eculizumab Sales Market Share (%) of Manufacturers 2014-2020
Figure South America Eculizumab Sales Market Share (%) in 2014
Figure South America Eculizumab Sales Market Share (%) in 2020
Table South America Eculizumab Revenue (M USD) of Manufacturers 2014-2020
Table South America Eculizumab Revenue Market Share (%) of Manufacturers 2014-2020
Figure South America Eculizumab Revenue Market Share (%) in 2014
Figure South America Eculizumab Revenue Market Share (%) in 2020
Table South America Eculizumab Price (USD/Unit) of Manufacturers 2014-2020
Figure South America Eculizumab Price (USD/Unit) of Manufacturers in 2014
Figure South America Eculizumab Price (USD/Unit) of Manufacturers in 2020
Table South America Eculizumab Gross Margin of Manufacturers 2014-2020
Figure South America Eculizumab Gross Margin of Manufacturers in 2014
Figure South America Eculizumab Gross Margin in 2020
Figure South America Eculizumab Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Global Eculizumab Sales (K Units) by Regions 2014-2020
Table Global Eculizumab Sales Market Share (%) by Regions 2014-2020
Figure Global Eculizumab Sales Market Share (%) by Regions in 2014
Figure Global Eculizumab Sales Market Share (%) by Regions in 2020
Table Global Eculizumab Revenue (M USD) by Regions 2014-2020
Table Global Eculizumab Revenue Market Share (%) by Regions 2014-2020
Figure Global Eculizumab Revenue Market Share (%) by Regions in 2014
Figure Global Eculizumab Revenue Market Share (%) by Regions in 2020
Table Global Eculizumab Price (USD/Unit) by Regions 2014-2020
Figure Global Eculizumab Price (USD/Unit) by Regions in 2014
Figure Global Eculizumab Price (USD/Unit) by Regions in 2020
Table Global Eculizumab Gross Margin by Regions 2014-2020
Figure Global Eculizumab Gross Margin by Regions in 2014
Figure Global Eculizumab Gross Margin by Regions in 2020
Figure Global Eculizumab Sales (K Units) and Growth Rate 2014-2020
Figure Global Eculizumab Revenue (M USD) and Growth Rate 2014-2020
Figure China Eculizumab Sales (K Units) and Growth Rate 2014-2020
Figure China Eculizumab Revenue (M USD) and Growth Rate 2014-2020
Figure USA Eculizumab Sales (K Units) and Growth Rate 2014-2020
Figure USA Eculizumab Revenue (M USD) and Growth Rate 2014-2020
Figure Europe Eculizumab Sales (K Units) and Growth Rate 2014-2020
Figure Europe Eculizumab Revenue (M USD) and Growth Rate 2014-2020
Figure Japan Eculizumab Sales (K Units) and Growth Rate 2014-2020
Figure Japan Eculizumab Revenue (M USD) and Growth Rate 2014-2020
Figure Korea Eculizumab Sales (K Units) and Growth Rate 2014-2020
Figure Korea Eculizumab Revenue (M USD) and Growth Rate 2014-2020
Figure India Eculizumab Sales (K Units) and Growth Rate 2014-2020
Figure India Eculizumab Revenue (M USD) and Growth Rate 2014-2020
Figure Southeast Asia Eculizumab Sales (K Units) and Growth Rate 2014-2020
Figure Southeast Asia Eculizumab Revenue (M USD) and Growth Rate 2014-2020
Figure South America Eculizumab Sales (K Units) and Growth Rate 2014-2020
Figure  South AmericaEculizumab  Revenue (M USD) and Growth Rate 2014-2020
Table Upstream Source for Manufacturers
Table Manufacture Technology of Eculizumab
Figure Cost Structure of Eculizumab in 2020
Table Global Eculizumab Production (K Units) by Regions 2021-2026
Table Global Eculizumab Production Market Share (%) by Regions 2021-2026
Figure Global Eculizumab Production Market Share (%) by Regions in 2020
Figure Global Eculizumab Production Market Share (%) by Regions in 2024
Table Global Eculizumab Revenue (M USD) by Regions 2021-2026
Table Global Eculizumab Revenue Market Share (%) by Regions 2021-2026
Figure Global Eculizumab Revenue Market Share (%) by Regions in 2020
Figure Global Eculizumab Revenue Market Share (%) by Regions in 2024
Figure Global Eculizumab Production (K Units) and Growth Rate 2021-2026
Figure Global Eculizumab Revenue (M USD) and Growth Rate 2021-2026
Figure China Eculizumab Production (K Units) and Growth Rate 2021-2026
Figure China Eculizumab Revenue (M USD) and Growth Rate 2021-2026
Figure USA Eculizumab Production (K Units) and Growth Rate 2021-2026
Figure USA Eculizumab Revenue (M USD) and Growth Rate 2021-2026
Figure Europe Eculizumab Production (K Units) and Growth Rate 2021-2026
Figure Europe Eculizumab Revenue (M USD) and Growth Rate 2021-2026
Figure Japan Eculizumab Production (K Units) and Growth Rate 2021-2026
Figure Japan Eculizumab Revenue (M USD) and Growth Rate 2021-2026
Figure Korea Eculizumab Production (K Units) and Growth Rate 2021-2026
Figure Korea Eculizumab Revenue (M USD) and Growth Rate 2021-2026
Figure India Eculizumab Production (K Units) and Growth Rate 2021-2026
Figure India Eculizumab Revenue (M USD) and Growth Rate 2021-2026
Figure Southeast Asia Eculizumab Production (K Units) and Growth Rate 2021-2026
Figure Southeast Asia Eculizumab Revenue (M USD) and Growth Rate 2021-2026
Figure South America Eculizumab Production (K Units) and Growth Rate 2021-2026
Figure South America Eculizumab Revenue (M USD) and Growth Rate 2021-2026
Table Global Eculizumab Production (K Units) by Types 2021-2026
Figure Global Eculizumab Production Market Share (%) by Types in 2020
Figure Global Eculizumab Production Market Share (%) by Types in 2024
Table Plasma Exchange Production (K Units) and Growth Rate
Table Plasma Exchange Revenue (M USD) and Growth Rate
Table Plasma Infusion Production (K Units) and Growth Rate
Table Plasma Infusion Revenue (M USD) and Growth Rate
Table Global Eculizumab Sales Forecast by Application 2021-2026
Figure Global Eculizumab Sales Market Share (%) by Application in 2020
Figure Global Eculizumab Sales Market Share (%) by Application in 2025
Figure PNH Sales and Growth Rate 2021-2026
Figure aHUS Sales and Growth Rate 2021-2026
Figure Other Sales and Growth Rate 2021-2026
Figure Global Eculizumab Price (USD/Unit) Trend 2021-2026
Figure Global Eculizumab Gross Profit Trend 2021-2026